Skip to main content
    P

    Praxis Precision Medicines Inc (PRAX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $305.06
    -5.21 (-1.68%)

    Market Cap: $8.67B

    Last updated: Nov 17, 2026 at 4:42 PM ET

    Praxis Precision Medicines Inc (PRAX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Praxis Precision Medicines (PRAX) has a market cap of $8.67B and an enterprise value of $8.31B. Its share count is up 32.77% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 4.17% below the market cap, as cash exceeds debt.

    Market Cap$8.67B
    Enterprise Value$8.31B
    Latest price (Nov 17, 2026)$305.06

    Key Dates

    The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 17, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.16% in the quarter ended Sep 30, 2026 and grew 24.30% a year over 2 years.

    Shares Outstanding29.18M
    Shares Change (YoY)+32.77%
    Shares Change (QoQ)+0.16%
    Share Count Growth (2Y CAGR)+24.30%

    Price Statistics

    The stock is up 63.64% over 52 weeks and trades 5.88% above its 50-day average.

    Beta (1Y)1.58
    52-Week Change+63.64%
    1-Month Change+17.25%
    3-Month Change-21.01%
    6-Month Change-4.85%
    5-Year Change-8.31%
    Total Return (1Y)+63.64%
    Total Return (3Y CAGR)+170.22%
    Total Return (5Y CAGR)+1.61%
    Return vs SPY (1Y)+54.12%
    Max Drawdown (1Y)-38.13%
    Max Drawdown (3Y)-68.64%
    Sharpe Ratio (1Y)0.69
    Correlation with SPY (1Y)0.30
    50-Day Average$288.12
    200-Day Average$314.54
    52-Week Range$160.11 to $392.70
    RSI (14 Days)53.1
    Average Volume (20 Days)478.21K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 14.53x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio14.53x
    Quick Ratio14.53x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -28.54% and return on assets is -27.39% over the last 12 months.

    Return on Equity (ROE)-28.54%
    Return on Assets (ROA)-27.39%
    Return on Capital Employed (ROCE)-28.54%
    ROA (5Y Average)-90.66%
    ROIC (5Y Average)-27.28%

    Scores

    PRAX has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$28.00K
    Operating Income-$406.72M
    Pretax Income-$359.43M
    Net Income-$359.43M
    EBIT-$359.43M
    Reported EPS (TTM)-$12.80

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 96.18% of the $1.31B in total assets.

    Cash and Equivalents$361.85M
    Total Debt$0
    Net Cash$361.85M
    Net Cash Per Share$12.40
    Working Capital$710.30M
    Shareholder Equity$1.26B
    Book Value Per Share$43.17
    Total Assets$1.31B
    Total Liabilities$52.50M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.86M of capital spending, operating cash flow left -$323.62M of free cash flow.

    Operating Cash Flow-$321.76M
    Capital Expenditures$1.86M
    Free Cash Flow-$323.62M
    FCF Per Share-$11.59
    Depreciation and Amortization$2.16M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)+125.27%
    Tangible Book Per Share Growth (2Y CAGR)+125.27%

    Revenue and profit by year

    Dividends and Yields

    PRAX does not pay a dividend.

    Buyback Yield-13.87%
    Shareholder Yield-13.87%

    Stock Splits

    The last split was a 1-for-15 reverse split on Nov 29, 2023.

    Last Split DateNov 29, 2023
    Split TypeReverse split
    Split Ratio1:15

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About PRAX

    What is PRAX's market cap?

    Praxis Precision Medicines has a market cap of $8.67B. Its enterprise value, which adds debt and subtracts cash, is $8.31B.

    How many shares of PRAX are outstanding?

    Praxis Precision Medicines has 29.18M shares outstanding. The count is up 32.77% from a year earlier.

    Does PRAX pay a dividend?

    No. Praxis Precision Medicines does not pay a dividend.

    How much debt does PRAX have?

    Praxis Precision Medicines has $0 of total debt and $361.85M of cash and equivalents, a net cash position of $361.85M.